Oramed Pharmaceuticals, Inc. (ORMP)
5.24
+0.03
(+0.58%)
USD |
NASDAQ |
Aug 26, 10:38
Oramed Pharmaceuticals Shareholders Equity (Quarterly) : 317.47M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 317.47M |
| March 31, 2026 | 238.28M |
| December 31, 2025 | 199.74M |
| September 30, 2025 | 203.28M |
| June 30, 2025 | 154.53M |
| March 31, 2025 | 140.81M |
| December 31, 2024 | 146.26M |
| September 30, 2024 | 156.44M |
| June 30, 2024 | 177.06M |
| March 31, 2024 | 166.64M |
| December 31, 2023 | 163.82M |
| September 30, 2023 | 149.13M |
| June 30, 2023 | 151.55M |
| March 31, 2023 | 150.97M |
| December 31, 2022 | 151.81M |
| September 30, 2022 | 153.81M |
| June 30, 2022 | 153.70M |
| March 31, 2022 | 162.35M |
| August 31, 2021 | 115.77M |
| May 31, 2021 | 68.12M |
| February 28, 2021 | 49.44M |
| November 30, 2020 | 28.21M |
| August 31, 2020 | 32.88M |
| May 31, 2020 | 34.11M |
| February 29, 2020 | 16.09M |
| Date | Value |
|---|---|
| November 30, 2019 | 17.16M |
| August 31, 2019 | 19.39M |
| May 31, 2019 | 21.56M |
| February 28, 2019 | 25.35M |
| November 30, 2018 | 28.86M |
| August 31, 2018 | 31.11M |
| May 31, 2018 | 16.66M |
| February 28, 2018 | 20.48M |
| November 30, 2017 | 22.74M |
| August 31, 2017 | 19.24M |
| May 31, 2017 | 19.81M |
| February 28, 2017 | 21.32M |
| November 30, 2016 | 23.99M |
| August 31, 2016 | 26.19M |
| May 31, 2016 | 30.98M |
| February 29, 2016 | 32.70M |
| November 30, 2015 | 22.54M |
| August 31, 2015 | 24.83M |
| May 31, 2015 | 21.33M |
| February 28, 2015 | 22.34M |
| November 30, 2014 | 23.70M |
| August 31, 2014 | 20.79M |
| May 31, 2014 | 21.97M |
| February 28, 2014 | 23.33M |
| November 30, 2013 | 7.305M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 33.88B |
| Pfizer Inc. | 85.19B |
| Yarrow Bioscience, Inc. | 22.06M |
| Liquidia Corp. | 195.11M |
| NRX Pharmaceuticals, Inc. | -0.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 369.64M |
| Total Liabilities (Quarterly) | 52.17M |
| Debt to Equity Ratio | 0.0023 |
| Current Ratio | 4.977 |
| Net Debt Paydown Yield | -0.04% |